{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:11:16Z","timestamp":1774375876708,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000916","name":"MetLife Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115568"],"award-info":[{"award-number":["115568"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["RYC-2013-13054"],"award-info":[{"award-number":["RYC-2013-13054"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.nicl.2019.101801","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T11:19:44Z","timestamp":1554117584000},"page":"101801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals"],"prefix":"10.1016","volume":"23","author":[{"given":"Carles","family":"Falcon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-2224","authenticated-orcid":false,"given":"Gemma C.","family":"Mont\u00e9-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-0642","authenticated-orcid":false,"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2019.101801_bb0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.0000000000001859","article-title":"Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease","volume":"85","author":"Alcolea","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2019.101801_bb0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.neurobiolaging.2015.03.001","article-title":"Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease","volume":"36","author":"Alcolea","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2019.101801_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nurt.2007.05.011","article-title":"Diffusion tensor imaging of the brain","volume":"4","author":"Alexander","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nicl.2019.101801_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00702-010-0534-0","article-title":"Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints","volume":"118","author":"Antonell","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nicl.2019.101801_bb0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101801_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2019.101801_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"Bonneh-Barkay","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nicl.2019.101801_bb0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2019.101801_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/156720511795256080","article-title":"The early involvement of the innate immunity in the pathogenesis of lateonset Alzheimers Disease: neuropathological, epidemiological and genetic evidence","volume":"8","author":"Eikelenboom","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nicl.2019.101801_bb0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nicl.2018.04.016","article-title":"Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: a study of two independent datasets","volume":"19","author":"Falcon","year":"2018","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2019.101801_bb0055","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/cercor\/bhp279","article-title":"Brain atrophy in healthy aging is related to CSF levels of A\u03b21\u201342","volume":"20","author":"Fjell","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nicl.2019.101801_bb0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2010-100678","article-title":"Increased cortical thickness and caudate volume precede atrophy in psen1 mutation carriers","volume":"22","author":"Fortea","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101801_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid \u00df-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2019.101801_bb0070","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.neurobiolaging.2015.06.027","article-title":"Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype","volume":"36","author":"Gispert","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2019.101801_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neurobiolaging.2015.10.022","article-title":"CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD","volume":"38","author":"Gispert","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2019.101801_bb0080","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jalz.2016.06.005","article-title":"Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease","volume":"12","author":"Gispert","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2019.101801_bb0085","first-page":"50","article-title":"The APOE \u03b54 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2","volume":"6","author":"Gispert","year":"2017","journal-title":"Alzheimer's Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.nicl.2019.101801_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pscychresns.2017.10.007","article-title":"What can DTI tell about early cognitive impairment? \u2013 differentiation between MCI subtypes and healthy controls by diffusion tensor imaging","volume":"272","author":"Gyebn\u00e1r","year":"2018","journal-title":"Psychiatry Res. Neuroimag."},{"key":"10.1016\/j.nicl.2019.101801_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2019.101801_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0182-1","article-title":"Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease","volume":"8","author":"Henjum","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nicl.2019.101801_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nicl.2019.101801_bb0110","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nn.3554","article-title":"The microglial sensome revealed by direct RNA sequencing","volume":"16","author":"Hickman","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nicl.2019.101801_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuroimage.2007.07.053","article-title":"Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification","volume":"39","author":"Hua","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2019.101801_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuroimage.2009.06.043","article-title":"A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging","volume":"48","author":"Hutton","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2019.101801_bb0125","series-title":"FSL","author":"Jenkinson","year":"2012"},{"key":"10.1016\/j.nicl.2019.101801_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nicl.2019.101801_bb0135","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.15252\/embj.201796516","article-title":"The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism","volume":"36","author":"Kleinberger","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.nicl.2019.101801_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073021","article-title":"Diffusion weighted image denoising using overcomplete local PCA","volume":"8","author":"Manj\u00f3n","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nicl.2019.101801_bb0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2019.101801_bb0150","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.15252\/embr.201743922","article-title":"TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury","volume":"18","author":"Mazaheri","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nicl.2019.101801_bb0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nicl.2013.07.006","article-title":"Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging","volume":"3","author":"Nir","year":"2013","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.nicl.2019.101801_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2012-120787","article-title":"Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia","volume":"33","author":"Olsson","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101801_bb0165","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2019.101801_bb0170","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nicl.2019.101801_bb0175","first-page":"1","article-title":"Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults","author":"Racine","year":"2017","journal-title":"Brain Imag. Behav."},{"key":"10.1016\/j.nicl.2019.101801_bb0180","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3233\/JAD-161146","article-title":"Inflammation, amyloid, and atrophy in the aging brain: relationships with longitudinal changes in cognition","volume":"58","author":"Sala-Llonch","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101801_bb0185","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nicl.2019.101801_bb0190","first-page":"1","article-title":"Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury","volume":"8","author":"Su\u00e1rez-calvet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nicl.2019.101801_bb0195","first-page":"1","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2019.101801_bb0200","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nicl.2019.101801_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2019.101801_bb0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in Alzheimer's disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219301512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219301512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:20:52Z","timestamp":1761970852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158219301512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":42,"alternative-id":["S2213158219301512"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101801","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101801"}}